MAPT and tauopathy: An example of its potential is represented, for instance, by the fact that through its application, and profiting from the relatively easy feasibility of ZF with a genetically encoded fluorescent Tau biosensor (reporting in vivo accumulation of human Tau species), it has been recently proposed that there is a link between traumatic brain injury, subsequent tauopathy, and PTE [111].